By Rosalind Beck Reviews Labels Evidence

SlimTide, reviewed: a dozen named ingredients and not one published amount

A July launch release for a probiotic-and-botanical weight-management capsule puts 'Supplement Facts' in its own headline. It names three bacterial strains and nine other ingredients, and attaches a number to none of them.

A headline made a promise, so we went looking for the thing it promised. The launch announcement for SlimTide, dated 30 July and carried by the paper on 31 July 2026, advertises in its own title that it “Highlights Ingredients, Supplement Facts”. That is unusual for a launch release to volunteer, and a reader would expect a panel underneath it.

There is no panel. There is a list — a long one — and that difference is the whole review.

One limit. This is an assessment of what the company has published, not of a bottle; where the release names a strain or an extract, that is a claim the company has made, not a fact established.

What the release actually publishes

The missing number is the only number

For a probiotic, the count is the dose. The name tells you which organism; the colony-forming unit figure tells you how much of it. A release that names three organisms and publishes no count for any of them has given a buyer the label of a dose without the dose. The release calls the bacteria a proprietary blend and names them anyway — the easier half of a disclosure, and not the half that decides anything.

Akkermansia muciniphila is the name doing the most work here, and the release does not say how many cells the capsule holds, whether they are live, or in what preparation. Attaching the name to a capsule and nothing else borrows the organism’s interest without inheriting one of its conditions.

Then the second half of the formula

Behind the strains sits a familiar botanical stack, seven ingredients deep. Not one carries a figure.

Do the arithmetic and you get as far as the first step. The method here is to set a published dose beside the dose used in the work the marketing gestures at, and show the gap. With the numerator absent, no gap can be measured — and a formula that cannot be measured cannot be defended either. Every question goes back to the company, which has answered none of them in the document it chose to publish.

There is a further squeeze the release ignores. Twelve named ingredients, plus unnamed vitamins and minerals, in one capsule taken once a day. A capsule has a fixed internal volume; the more names inside it, the less of each there can be, and the split is what has not been published. We have written before about a fibre with a published daily amount attached, and how much work that number does — the difference between an ingredient and an inclusion.

The claims, weighed against the evidence section

The release describes the product as supporting appetite control and body weight management, and speaks of appetite regulation and metabolic function. Some of the restraint is real. There is no before-and-after framing and no promised figure, and the document draws a line between these capsules and approved medication.

It does not stop there, though. The headline calls the formula effective; the opening paragraph calls the support science-backed; and both are attached to nothing. No trial is named — not for the formula, not for a single ingredient at a stated amount. What a supplement says about itself is not something the Food and Drug Administration evaluates before it goes on sale, nothing here is intended to diagnose, treat, cure or prevent any disease, and no capsule substitutes for medical care. Where a clinician is already helping with weight, that conversation is the one that counts; this is a consumer purchase, and nothing more.

Pros and cons

Verdict

Judged as marketing, this is middling: it names its organisms and promises no figure, but it calls itself effective and science-backed on no visible authority. Judged as a label, it is not one. A list of ingredients is an intention. A panel with amounts is a commitment, and the commitment is what lets anybody outside the company argue with the product.

The fix sits with the company: publish the panel, with CFU counts and milligrams, and this becomes checkable overnight. Until then, a buyer is asked to pay an unpublished price for unpublished amounts of twelve named things, on the strength of a headline that says the facts are here when they are not.